Article metrics

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

 

Online download statistics by month:

Online download statistics by month: December 2021 to April 2022

AbstractFullPdf
Dec 202114171411534
Jan 2022210221451036
Feb 202210591046546
Mar 2022812807455
Apr 2022475483286
Total586558922857